{"payload":{"header_redesign_enabled":false,"results":[{"id":"552460579","archived":false,"color":"#B0CE4E","followers":0,"has_funding_file":false,"hl_name":"witekgabriela/StructuralStudy_ALKCompoundMutations","hl_trunc_description":"Lorlatinib is a third generation small molecule inhibitor developed to target mutated anaplastic lymphoma kinase (ALK). Treatment with lo…","language":"Component Pascal","mirror":false,"owned_by_organization":false,"public":true,"repo":{"repository":{"id":552460579,"name":"StructuralStudy_ALKCompoundMutations","owner_id":101832204,"owner_login":"witekgabriela","updated_at":"2023-03-30T14:07:58.188Z","has_issues":true}},"sponsorable":false,"topics":[],"type":"Public","help_wanted_issues_count":0,"good_first_issue_issues_count":0,"starred_by_current_user":false}],"type":"repositories","page":1,"page_count":1,"elapsed_millis":84,"errors":[],"result_count":1,"facets":[],"protected_org_logins":[],"topics":null,"query_id":"","logged_in":false,"sign_up_path":"/signup?source=code_search_results","sign_in_path":"/login?return_to=https%3A%2F%2Fgithub.com%2Fsearch%3Fq%3Drepo%253Awitekgabriela%252FStructuralStudy_ALKCompoundMutations%2B%2Blanguage%253A%2522Component%2BPascal%2522","metadata":null,"csrf_tokens":{"/witekgabriela/StructuralStudy_ALKCompoundMutations/star":{"post":"vXO2w_uLyCJZ74zU8_D27Y8C65MJNZvj4d-uj3HiU1f7LIH62dpoVwocYaLDPILhpWYwlVSm3Va71eBHCzG0uQ"},"/witekgabriela/StructuralStudy_ALKCompoundMutations/unstar":{"post":"UpBaX2du6cFzpCD1nxM21Xh98K6tW85YbK-SdFia5lljd-KzZO9Y2VNFAr3hnZTK1nmHCc_WmV6iFl1hPYNk0A"},"/sponsors/batch_deferred_sponsor_buttons":{"post":"8ftHL7KxAW8fClhUn7uUvcqUFDkiv8I3C0uku5xXxSpog6f-S61IWru73sf6pGaekdNP8rwid2Te_g-7BpSBCg"}}},"title":"Repository search results"}